AMLX
Amylyx Pharmaceuticals Inc
Biopharmaceutical company developing treatments for neurodegenerative diseases and endocrine conditions
CUSIP: 03237H101HealthcareUS1 holder
Total Value
$63.90M
Total Shares
2.96M
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Viking Global Investors
$63.90M2.96M sharesUnchanged